Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, indicating a minor metadata update with no changes to study details or results.
    Difference
    0.0%
    Check dated 2026-03-18T18:12:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T15:28:12.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Site revision v3.4.2 was added and the government funding status notice from v3.4.1 was removed; no study content changes were made. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T01:59:26.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A government funding lapse notice banner was added and the site was updated to revision 3.4.1, replacing 3.4.0.
    Difference
    0.2%
    Check dated 2026-02-03T23:25:11.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Added a Show glossary option and new metadata items: Last Update Submitted that Met QC Criteria and No FEAR Act Data, plus a revision note indicating Revision: v3.4.0. Removed the corresponding older items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-27T20:55:13.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Added a Washington Locations section and updated the page revision from v3.3.2 to v3.3.3; removed HHS Vulnerability Disclosure and Washington Locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:36:54.000Z thumbnail image

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.